The glioblastoma is an aggressive form of brain tumors with approximately 120,000 new cases worldwide. Although therapeutic advances could be achieved in the last few years, medical needs is always still enormously high after effective treatment options to patients who suffer from this terrible disease, to help. The results of the previous study for the NanoTherm MagForce therapy are promising. I look forward to be able to participate in this new study. It aims to validate the results in comparison to the currently established standard therapy in a larger patient population. This allows meaningful conclusions Let’s about the potential of this new approach to treating this desperate so far Patients”, added Prof.
Dr. Walter of Santos, Director of the clinic for neurosurgery and neuro-oncology at the University Hospital of Munster, President of the Neuroonkologischen Association (NOA) and head of this clinical study. NanoTherm therapy the NanoTherm is a novel process for the local treatment of solid tumors. Principle of the method is the direct introduction of superparamagnetic nanoparticles in a tumor and their subsequent warming in an alternating magnetic field. The nano-particles are very small (diameter about 15 nanometers) and contain iron oxide with a shell made of Aminosilanes. The particles are through a magnetic field, which changes its polarity up to 100,000 times per second, put into vibration and thereby generate heat. Depending on the achieved temperatures in the tumor and the duration of treatment the tumor cells are destroyed either directly (thermal ablation), or they are more sensitive to an accompanying radio – or chemotherapy (hyperthermia). With this new Treatment approach is thus able to fight the tumor from the inside out and to protect surrounding healthy tissue.
The nano-particles remain in the treatment area, so repeated treatments and integration into multimodal therapy concepts are possible. The NanoTherm therapy is approved in 27 European countries. Nano launch: The Nano launch AG is a leading nanotechnology investment company. The company invested venture capital (venture capital, VC) in young promising nanotechnology companies. Thereby, Nanostart invests globally and at different stages of development. The investments of the company focus on innovative sectors such as Cleantech, life sciences and IT/electronics. Nanostart invests directly in nanotechnology companies, or through regional nanotechnology Fund. The headquarters of nano start AG is Frankfurt am Main. MagForce: The MagForce AG is a leader in the field of nanomedicine medical technology company with a focus in Oncology. The company’s own treatment method NanoTherm allows the targeted treatment of solid tumors of the intratumoral distribution of heat therapy enabling superparamagnetic nanoparticles. NanoPlan NanoTherm and NanoActivatorTM are part of the therapy and have a EU-wide approval as medical devices for the treatment of brain tumors. MagForce, NanoPlan NanoTherm and NanoActivatorTM are trademarks of MagForce AG in various countries.